Cigna Group stock holds firm after Q2 beat
Published on 08/25/2026 at 15:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cigna Group (ISIN US1255231003) stock held near $280 after the company reported second-quarter 2026 earnings of $7.78 per share on July 30, 2026, ahead of the $7.60 consensus, while revenue reached $70.04 billion and full-year 2026 guidance was set at at least $30.45 per share.
The filing trail is current as well: a Form 8-K dated August 25, 2026 confirms that the company issued the press release for the quarter ended August 2, 2026. The balance of the story is the same one Wall Street has been pricing in for weeks - steady earnings power, a modest revenue miss versus the $70.14 billion estimate, and a valuation that still leaves room for debate.
Quarterly numbers stay the anchor
The latest quarter also showed net margin of 2.27% and return on equity of 19.75%, according to the same earnings snapshot. Revenue rose 6.7% year over year from the prior-year quarter, while EPS improved from $7.20 a year earlier to $7.78.
That is the key comparison investors can actually trade on: earnings beat consensus by $0.18 per share even as sales came in $100 million short of expectations. The mix matters because Cigna's earnings power remains stronger than the top-line gap suggests.
Guidance and consensus
FY 2026 guidance now points to at least $30.45 per share, and one current market snapshot pegs the stock's market value at $74.07 billion with a P/E ratio of 11.60 and a beta of 0.29. A separate consensus view in the same set puts full-year earnings at $30.51 per share, only slightly above management's floor.
That narrow spread between guidance and consensus suggests analysts are treating the quarter as confirmation rather than a reset. The number that stands out is the gap between the $30.45 company guide and the $30.51 estimate, which is small enough to keep attention on execution.
What the business sells
The Cigna Group's report centers on health services, with Evernorth and Cigna Healthcare still framing the company's operating mix. For investors, the product story is less about one launch than about whether pharmacy and medical services can keep translating volume into earnings at the current pace.
The stock last changed hands at $280.32 in a same-day market snapshot, and the market cap was listed at $74.07 billion. The shares remain tied to whether Cigna can keep delivering earnings above consensus while defending that margin profile.
Fact box
Company: The Cigna Group
ISIN: US1255231003
Ticker: CI
Exchange: NYSE
Market cap: $74.07 billion
Sector / Industry: Health Care / Managed Health Care
Index membership: S&P 500
More on Cigna Group stock
The Cigna Group is a global health company with Evernorth Health Services and Cigna Healthcare at its core.
Closing stock view
Cigna Group stock was last quoted at $280.32, with the session snapshot showing a market cap of $74.07 billion and a P/E ratio of 11.60.
